402 related articles for article (PubMed ID: 22840417)
41. Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies.
Zoumpoulakis P; Camoutsis Ch; Pairas G; Soković M; Glamočlija J; Potamitis C; Pitsas A
Bioorg Med Chem; 2012 Feb; 20(4):1569-83. PubMed ID: 22264752
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety.
Zhang K; Wang P; Xuan LN; Fu XY; Jing F; Li S; Liu YM; Chen BQ
Bioorg Med Chem Lett; 2014 Nov; 24(22):5154-6. PubMed ID: 25442303
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives.
Siddiqui N; Alam MS; Ahsan W
Acta Pharm; 2008 Dec; 58(4):445-54. PubMed ID: 19103578
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
46. [Synthesis and antibacterial activity of 3-(4-piperazin-1-yl-phenyl)-s-triazolo [3,4-b] [1,3,4] thiadiazole hydrochlorides].
Hu GQ; Sun MF; Xie SQ; Huang WL; Zhang HB
Yao Xue Xue Bao; 2007 Jan; 42(1):54-7. PubMed ID: 17520807
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents.
Gellis A; Kovacic H; Boufatah N; Vanelle P
Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567
[TBL] [Abstract][Full Text] [Related]
49. Anticancer activity of new compounds using benzimidazole as a scaffold.
Rashid M; Husain A; Shaharyar M; Sarafroz M
Anticancer Agents Med Chem; 2014; 14(7):1003-18. PubMed ID: 24827531
[TBL] [Abstract][Full Text] [Related]
50. New sulphonamide and carboxamide derivatives of acyclic C-nucleosides of triazolo-thiadiazole and the thiadiazine analogues. Synthesis, anti-HIV, and antitumor activities. Part 2.
Al-Masoudi NA; Al-Soud YA
Nucleosides Nucleotides Nucleic Acids; 2008 Sep; 27(9):1034-44. PubMed ID: 18711666
[TBL] [Abstract][Full Text] [Related]
51. New 3-(1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one-based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis-inducing agents.
Gaikwad NB; Bansode S; Biradar S; Ban M; Srinivas N; Godugu C; Yaddanapudi VM
Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100074. PubMed ID: 34346099
[TBL] [Abstract][Full Text] [Related]
52. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
[TBL] [Abstract][Full Text] [Related]
55. Efficient access to novel androsteno-17-(1',3',4')-oxadiazoles and 17β-(1',3',4')-thiadiazoles via N-substituted hydrazone and N,N'-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro.
Kovács D; Wölfling J; Szabó N; Szécsi M; Minorics R; Zupkó I; Frank É
Eur J Med Chem; 2015 Jun; 98():13-29. PubMed ID: 25993309
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.
Güzeldemirci NU; Küçükbasmaci O
Eur J Med Chem; 2010 Jan; 45(1):63-8. PubMed ID: 19939519
[TBL] [Abstract][Full Text] [Related]
58. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
59. Benzothiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kaur M
Eur J Med Chem; 2012 Aug; 54():447-62. PubMed ID: 22703845
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
